Ionis Pharmaceuticals Inc
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | -186.8% | – | – | – | – | |
| – | +1.1% | +0.0% | -1.3% | -35.2% | +45.7% | +91,318.3% | -99.9% | +117.3% | -38.1% | -7.6% | -49.4% | – | |
| – | +20.7% | +0.0% | -2.0% | +4.1% | +13.0% | -17.8% | -0.1% | +4.9% | -95,280.6% | – | +5.4% | – | |
| – | – | – | – | – | -144.0% | – | – | – | -65.8% | -3,160.5% | – | – | |
| – | +76.8% | +0.0% | +253.6% | -55.3% | +181.5% | -50.7% | +13.5% | -76.8% | +544.0% | +2.2% | -26.1% | – | |
| – | +10.8% | +0.0% | -17.9% | -645.7% | – | +149.9% | -170.4% | – | -559.3% | – | -95.6% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | +92,702.1% | -99.9% | -4.8% | +2.5% | – | -100.0% | +982,972.7% | – | |
| – | – | +0.0% | -89.2% | +19,299.6% | -108.9% | – | -43.3% | +6,413.1% | +627.9% | -90.3% | -64.6% | – | |
| – | – | – | – | – | -327.8% | – | +49.7% | +23.9% | -17.3% | -686.3% | – | – | |
| – | – | – | – | – | – | – | – | -198.3% | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 5, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.